- CDC News
- Adult Immunization
- Hepatology
- Rare Disorders
- Pediatric Immunization
- Weight Management
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Kidney Disease
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Geriatrics
- Infectious Disease
- Orthopedics
- Obesity Medicine
- Rheumatology
- Technology
- Oncology
- Nephrology
- Neurology
- Pulmonology
Respiratory Tripledemic 2022-23: Expert Update, Top Challenges
Distinguishing between influenza, COVID-19, and RSV and persuading vaccine-weary patients to get vaccinated are some of the challenges this season, says William Schaffner, MD.
"This has certainly been a distinctive season," said William Schaffner, MD, to Patient Care Online when asked about the current status of the 2022-2023 respiratory virus season.
This season is unique with the cocirculation of influenza, COVID-19, and respiratory syncytial virus (RSV). The "tripledemic," as it has been named, has brought challenges to clinicians caring for infected persons, such as diagnosing between the 3 respiratory diseases and persuading a vaccine weary population that they should get vaccinated, both with the influenza vaccine and the updated COVID-19 boosters. Below, Dr Schaffner gives a brief update on the current respiratory virus season and shares what his top challenges have been so far.
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.
